Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging ...Middle East

MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for its...

Hence then, the article about telix completes tlx250 cdx zircaix bla submission for kidney cancer imaging was published today ( Monday 03/06/2024 - 04:18 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging )

Also on site :

• ‘Motor City’ Review: Potsy Ponciroli’s Audacious Thriller — a Scorsese Opera without Dialogue — Announces the Arrival of a Startling Voice
• Skating Legend, Who Entered the 1988 Winter Olympics as an Underdog, Delivered One of Figure Skating's Greatest Routines
• Complain Campaign: Michelle Obama Is Angry the Media Treated Her As a Fashion Icon, Not a Great Orator